Skip to main content
    I

    IGC Pharma, Inc. (IGC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.19
    +0.00 (+0.11%)

    Market Cap: $20.54M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    IGC Pharma, Inc. (IGC) Earnings: Report Dates and Results

    Updated Nov 6, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, IGC Pharma reported EPS of -$0.02, in line with the -$0.02 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    31%(4/13)
    Avg Surprise
    -62.13%

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.02
    Range-$0.02 - -$0.02
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$0.03+20.0%
    60d ago-$0.03+20.0%
    30d ago-$0.03+20.0%
    7d ago-$0.020.0%
    Current-$0.02
    Revenue Consensus
    $280.00K
    Range$280.00K - $280.00K
    1 analysts
    Report date not yet scheduledPeriod ending Mar 31, 2027
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A

    Next Report

    IGC's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    Earnings History

    Of the 13 quarters below that had an estimate, IGC beat 4, missed 3 and matched 6. Revenue for the quarter ended Sep 30, 2026 was $328000, up 71.7% from $191000 a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.02-$0.02-$0.02 - -$0.020.00%In lineN/A10 up, 0 downNov 6, 2026$328000
    Jun 30, 2026-$0.03-$0.02-$0.02 - -$0.02-50.00%MissN/A20 up, 0 downAug 14, 2026$265000
    Mar 31, 2026-$0.02-$0.02-$0.02 - -$0.020.00%In lineN/A20 up, 0 downApr 3, 2026$317000
    Dec 31, 2025-$0.02-$0.02-$0.02 - -$0.020.00%In lineN/A11 up, 0 downFeb 18, 2026$350000
    Sep 30, 2025-$0.02-$0.02-$0.02 - -$0.020.00%In lineN/A21 up, 0 downNov 14, 2025$191000
    Jun 30, 2025-$0.01-$0.03-$0.03 - -$0.02+50.67%BeatN/A20 up, 0 downAug 14, 2025$328000
    Mar 31, 2025-$0.01-$0.02-$0.02 - -$0.02+50.00%BeatN/A21 up, 0 downJun 27, 2025$330000
    Dec 31, 2024-$0.02-$0.03-$0.03 - -$0.03+33.33%BeatN/A11 up, 0 downFeb 14, 2025$257000
    Sep 30, 2024-$0.02-$0.03-$0.03 - -$0.02+33.33%BeatN/A20 up, 0 downNov 12, 2024$412000
    Jun 30, 2024-$0.03-$0.03-$0.03 - -$0.020.00%In lineN/A21 up, 0 downAug 8, 2024$330000
    Mar 31, 2024-$0.40-$0.04-$0.04 - -$0.04-900.00%MissN/A10 up, 0 downJun 24, 2024$295000
    Dec 31, 2023-$0.05-$0.04N/A-25.00%MissN/AN/AN/AFeb 14, 2024$204000
    Sep 30, 2023-$0.05-$0.05N/A0.00%In lineN/AN/AN/ANov 9, 2023$291000
    Jun 30, 2023-$0.04N/AN/AN/AN/AN/AN/AN/AJul 7, 2023$555000
    Mar 31, 2023-$0.08N/AN/AN/AN/AN/AN/AN/AJun 30, 2023$165000
    Dec 31, 2022-$0.04N/AN/AN/AN/AN/AN/AN/AFeb 14, 2023$332000
    Sep 30, 2022-$0.05N/AN/AN/AN/AN/AN/AN/ANov 1, 2022$202000
    Jun 30, 2022-$0.05N/AN/AN/AN/AN/AN/AN/AAug 8, 2022$212000
    Mar 31, 2022-$0.13N/AN/AN/AN/AN/AN/AN/AJun 22, 2022$199000
    Dec 31, 2021-$0.05N/AN/AN/AN/AN/AN/AN/AFeb 10, 2022$142000
    Sep 30, 2021-$0.09N/AN/AN/AN/AN/AN/AN/AOct 29, 2021$56000
    Jun 30, 2021-$0.04N/AN/AN/AN/AN/AN/AN/AAug 11, 2021N/A
    Mar 31, 2021-$0.07N/AN/AN/AN/AN/AN/AN/AJun 14, 2021N/A
    Dec 31, 2020-$0.06N/AN/AN/AN/AN/AN/AN/AFeb 12, 2021$108000
    Sep 30, 2020-$0.04N/AN/AN/AN/AN/AN/AN/ANov 20, 2020$125000
    Jun 30, 2020-$0.05N/AN/AN/AN/AN/AN/AN/AJul 13, 2020$584000
    Mar 31, 2020-$0.08N/AN/AN/AN/AN/AN/AN/AJun 17, 2020$29000
    Dec 31, 2019-$0.04N/AN/AN/AN/AN/AN/AN/AFeb 10, 2020$573000
    Sep 30, 2019-$0.03N/AN/AN/AN/AN/AN/AN/ANov 6, 2019$1.82M
    Jun 30, 2019-$0.03N/AN/AN/AN/AN/AN/AN/AAug 9, 2019$1.65M
    Mar 31, 2019-$0.04N/AN/AN/AN/AN/AN/AN/AJun 17, 2019$1.54M
    Dec 31, 2018-$0.03N/AN/AN/AN/AN/AN/AN/AFeb 12, 2019$1.28M
    Sep 30, 2018-$0.03N/AN/AN/AN/AN/AN/AN/AOct 16, 2018$811000
    Jun 30, 2018-$0.02N/AN/AN/AN/AN/AN/AN/AAug 2, 2018$1.48M
    Mar 31, 2018-$0.02N/AN/AN/AN/AN/AN/AN/AJun 21, 2018$1.14M
    Dec 31, 2017-$0.02N/AN/AN/AN/AN/AN/AN/AFeb 20, 2018$762000
    Sep 30, 2017-$0.01N/AN/AN/AN/AN/AN/AN/ANov 20, 2017$235000
    Jun 30, 2017-$0.01N/AN/AN/AN/AN/AN/AN/AJul 14, 2017$52926
    Mar 31, 2017-$0.02N/AN/AN/AN/AN/AN/AN/AJun 30, 2017N/A
    Dec 31, 2016-$0.04N/AN/AN/AN/AN/AN/AN/AFeb 21, 2017$249801
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Mar 31, 2026 was -$0.07, after -$0.08 the year before. It was -$0.08 for the year ended Mar 31, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Mar 31, 2026-$0.07N/A
    Mar 31, 2025-$0.08N/A
    Mar 31, 2024-$0.54N/A
    Mar 31, 2023-$0.22N/A
    Mar 31, 2022-$0.31N/A
    Mar 31, 2021-$0.22N/A
    Mar 31, 2020-$0.18N/A
    Mar 31, 2019-$0.12N/A
    Mar 31, 2018-$0.06N/A
    Mar 31, 2017-$0.08N/A

    Frequently Asked Questions About IGC

    Did IGC beat earnings estimates last quarter?

    IGC Pharma reported EPS of -$0.02 for the quarter ended Sep 30, 2026, in line with the -$0.02 estimate.

    What EPS do analysts expect from IGC next quarter?

    The consensus EPS estimate for IGC Pharma for the quarter ending Dec 31, 2026 is -$0.02 from 1 analyst, with estimates from -$0.02 to -$0.02.

    How often does IGC beat earnings estimates?

    IGC Pharma beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of +10.50%.